Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
Tomsk National Research Medical Center of the Russian Academy of Sciences
ViroMissile, Inc.
Replimune Inc.
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Baylor College of Medicine
Nanjing Sanhome Pharmaceutical, Co., Ltd.
SystImmune Inc.
Eli Lilly and Company
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Shanghai Juncell Therapeutics
AstraZeneca
Sanofi
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
Novita Pharmaceuticals, Inc.
Lyell Immunopharma, Inc.
Monopar Therapeutics
Monopar Therapeutics
Columbia University
Thomas Jefferson University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Williams Cancer Foundation
Rutgers, The State University of New Jersey
Compugen Ltd
Vincerx Pharma, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Second Affiliated Hospital of Guangzhou Medical University
Celldex Therapeutics
Institut Paoli-Calmettes
Lebanese University
National Cancer Institute (NCI)
Corvus Pharmaceuticals, Inc.
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Lebanese University
Fate Therapeutics
Candel Therapeutics, Inc.
Canadian Cancer Trials Group
M.D. Anderson Cancer Center
Prelude Therapeutics
Quadriga Biosciences, Inc.
A&G Pharmaceutical Inc.